BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21654676)

  • 41. Aldehyde dehydrogenase 1A1 possesses stem-like properties and predicts lung cancer patient outcome.
    Li X; Wan L; Geng J; Wu CL; Bai X
    J Thorac Oncol; 2012 Aug; 7(8):1235-45. PubMed ID: 22617249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crosstalk between VEGF and MTA1 signaling pathways contribute to aggressiveness of breast carcinoma.
    Nagaraj SR; Shilpa P; Rachaiah K; Salimath BP
    Mol Carcinog; 2015 May; 54(5):333-50. PubMed ID: 24265228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1.
    Li LZ; Zhang CZ; Liu LL; Yi C; Lu SX; Zhou X; Zhang ZJ; Peng YH; Yang YZ; Yun JP
    Carcinogenesis; 2014 Feb; 35(2):469-78. PubMed ID: 24085799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biosynthesis of heparin/heparan sulfate: kinetic studies of the glucuronyl C5-epimerase with N-sulfated derivatives of the Escherichia coli K5 capsular polysaccharide as substrates.
    Hagner-McWhirter A; Hannesson HH; Campbell P; Westley J; Rodén L; Lindahl U; Li JP
    Glycobiology; 2000 Feb; 10(2):159-71. PubMed ID: 10642607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
    Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion.
    Jia D; Yan M; Wang X; Hao X; Liang L; Liu L; Kong H; He X; Li J; Yao M
    BMC Cancer; 2010 Jul; 10():364. PubMed ID: 20615257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nrf2-heme oxygenase-1 axis in mucoepidermoid carcinoma of the lung: Antitumoral effects associated with down-regulation of matrix metalloproteinases.
    Tertil M; Golda S; Skrzypek K; Florczyk U; Weglarczyk K; Kotlinowski J; Maleszewska M; Czauderna S; Pichon C; Kieda C; Jozkowicz A; Dulak J
    Free Radic Biol Med; 2015 Dec; 89():147-57. PubMed ID: 26393425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
    Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
    Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.
    Kong KL; Kwong DL; Fu L; Chan TH; Chen L; Liu H; Li Y; Zhu YH; Bi J; Qin YR; Law SY; Guan XY
    Cancer Res; 2010 Nov; 70(21):8832-41. PubMed ID: 20978196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential prognostic marker ubiquitin carboxyl-terminal hydrolase-L1 does not predict patient survival in non-small cell lung carcinoma.
    Orr KS; Shi Z; Brown WM; O'Hagan KA; Lappin TR; Maxwell P; Percy MJ
    J Exp Clin Cancer Res; 2011 Aug; 30(1):79. PubMed ID: 21878121
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proliferation of small cell lung cancer cell line reduced by knocking-down PROX1 via shRNA in lentivirus.
    Zhu SH; Shan CJ; Wu ZF; Xu SZ
    Anticancer Res; 2013 Aug; 33(8):3169-75. PubMed ID: 23898075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Substrate binding mode and catalytic mechanism of human heparan sulfate d-glucuronyl C5 epimerase.
    Debarnot C; Monneau YR; Roig-Zamboni V; Delauzun V; Le Narvor C; Richard E; Hénault J; Goulet A; Fadel F; Vivès RR; Priem B; Bonnaffé D; Lortat-Jacob H; Bourne Y
    Proc Natl Acad Sci U S A; 2019 Apr; 116(14):6760-6765. PubMed ID: 30872481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydrogen/deuterium exchange-LC-MS approach to characterize the action of heparan sulfate C5-epimerase.
    Babu P; Victor XV; Nelsen E; Nguyen TK; Raman K; Kuberan B
    Anal Bioanal Chem; 2011 Jul; 401(1):237-44. PubMed ID: 21573838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.
    Yu JA; Mauchley D; Li H; Meng X; Nemenoff RA; Fullerton DA; Weyant MJ
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1185-91. PubMed ID: 23079010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy.
    Brenner S; Klameth L; Riha J; Schölm M; Hamilton G; Bajna E; Ausch C; Reiner A; Jäger W; Thalhammer T; Buxhofer-Ausch V
    Cancer Lett; 2015 Jan; 356(2 Pt B):517-24. PubMed ID: 25301452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
    Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
    Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.
    Wang F; Grigorieva EV; Li J; Senchenko VN; Pavlova TV; Anedchenko EA; Kudryavtseva AV; Tsimanis A; Angeloni D; Lerman MI; Kashuba VI; Klein G; Zabarovsky ER
    PLoS One; 2008 Aug; 3(8):e3031. PubMed ID: 18725949
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.
    Hahn N; Heiden M; Seitz R; Salge-Bartels U
    J Cancer Res Clin Oncol; 2012 Apr; 138(4):695-703. PubMed ID: 22237453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.